These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

259 related articles for article (PubMed ID: 25329911)

  • 1. Upregulation of GPR109A in Parkinson's disease.
    Wakade C; Chong R; Bradley E; Thomas B; Morgan J
    PLoS One; 2014; 9(10):e109818. PubMed ID: 25329911
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A novel treatment target for Parkinson's disease.
    Wakade C; Chong R
    J Neurol Sci; 2014 Dec; 347(1-2):34-8. PubMed ID: 25455298
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Niacin Ameliorates Neuro-Inflammation in Parkinson's Disease via GPR109A.
    Giri B; Belanger K; Seamon M; Bradley E; Purohit S; Chong R; Morgan JC; Baban B; Wakade C
    Int J Mol Sci; 2019 Sep; 20(18):. PubMed ID: 31540057
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Involvement of the Niacin Receptor GPR109a in the LocalControl of Glucose Uptake in Small Intestine of Type 2Diabetic Mice.
    Wong TP; Chan LK; Leung PS
    Nutrients; 2015 Sep; 7(9):7543-61. PubMed ID: 26371038
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Niacin receptor GPR109A inhibits insulin secretion and is down-regulated in type 2 diabetic islet beta-cells.
    Wang N; Guo DY; Tian X; Lin HP; Li YP; Chen SJ; Fu YC; Xu WC; Wei CJ
    Gen Comp Endocrinol; 2016 Oct; 237():98-108. PubMed ID: 27570060
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential tissue and ligand-dependent signaling of GPR109A receptor: implications for anti-atherosclerotic therapeutic potential.
    Gaidarov I; Chen X; Anthony T; Maciejewski-Lenoir D; Liaw C; Unett DJ
    Cell Signal; 2013 Oct; 25(10):2003-16. PubMed ID: 23770183
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Niacin stimulates adiponectin secretion through the GPR109A receptor.
    Plaisance EP; Lukasova M; Offermanns S; Zhang Y; Cao G; Judd RL
    Am J Physiol Endocrinol Metab; 2009 Mar; 296(3):E549-58. PubMed ID: 19141678
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Distinct kinetic and spatial patterns of protein kinase C (PKC)- and epidermal growth factor receptor (EGFR)-dependent activation of extracellular signal-regulated kinases 1 and 2 by human nicotinic acid receptor GPR109A.
    Li G; Deng X; Wu C; Zhou Q; Chen L; Shi Y; Huang H; Zhou N
    J Biol Chem; 2011 Sep; 286(36):31199-212. PubMed ID: 21768093
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Niacin/β-hydroxybutyrate regulates milk fat and milk protein synthesis
    Chen J; Lin T; Zhang S; Yue X; Liu X; Wu C; Liang Y; Zeng X; Ren M; Chen F; Guan W; Zhang S
    Food Funct; 2023 Mar; 14(6):2642-2656. PubMed ID: 36866679
    [TBL] [Abstract][Full Text] [Related]  

  • 10. GPR109A as an anti-inflammatory receptor in retinal pigment epithelial cells and its relevance to diabetic retinopathy.
    Gambhir D; Ananth S; Veeranan-Karmegam R; Elangovan S; Hester S; Jennings E; Offermanns S; Nussbaum JJ; Smith SB; Thangaraju M; Ganapathy V; Martin PM
    Invest Ophthalmol Vis Sci; 2012 Apr; 53(4):2208-17. PubMed ID: 22427566
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Niacin and Butyrate: Nutraceuticals Targeting Dysbiosis and Intestinal Permeability in Parkinson's Disease.
    Karunaratne TB; Okereke C; Seamon M; Purohit S; Wakade C; Sharma A
    Nutrients; 2020 Dec; 13(1):. PubMed ID: 33374784
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neuroprotective Effects of Sodium Butyrate and Monomethyl Fumarate Treatment through GPR109A Modulation and Intestinal Barrier Restoration on PD Mice.
    Xu RC; Miao WT; Xu JY; Xu WX; Liu MR; Ding ST; Jian YX; Lei YH; Yan N; Liu HD
    Nutrients; 2022 Oct; 14(19):. PubMed ID: 36235813
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inflammation stimulates niacin receptor (GPR109A/HCA2) expression in adipose tissue and macrophages.
    Feingold KR; Moser A; Shigenaga JK; Grunfeld C
    J Lipid Res; 2014 Dec; 55(12):2501-8. PubMed ID: 25320346
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Deficiency of metabolite sensing receptor HCA2 impairs the salutary effect of niacin in hemorrhagic shock.
    Subramani K; Chu X; Warren M; Lee M; Lu S; Singh N; Raju R
    Biochim Biophys Acta Mol Basis Dis; 2019 Mar; 1865(3):688-695. PubMed ID: 30625381
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Effect of Metformin on the Expression of GPR109A, NF-κB and IL-1β in Peripheral Blood Leukocytes from Patients with Type 2 Diabetes Mellitus.
    Xu X; Lin S; Chen Y; Li X; Ma S; Fu Y; Wei C; Wang C; Xu W
    Ann Clin Lab Sci; 2017 Sep; 47(5):556-562. PubMed ID: 29066482
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nicotinic Acid Receptor GPR109A Exerts Anti-Inflammatory Effects Through Inhibiting the Akt/mTOR Signaling Pathway in MIN6 Pancreatic β cells.
    Li Z; Li X; Lin S; Chen Y; Ma S; Fu Y; Wei C; Xu W
    Ann Clin Lab Sci; 2017 Nov; 47(6):729-737. PubMed ID: 29263047
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Niacin lipid efficacy is independent of both the niacin receptor GPR109A and free fatty acid suppression.
    Lauring B; Taggart AK; Tata JR; Dunbar R; Caro L; Cheng K; Chin J; Colletti SL; Cote J; Khalilieh S; Liu J; Luo WL; Maclean AA; Peterson LB; Polis AB; Sirah W; Wu TJ; Liu X; Jin L; Wu K; Boatman PD; Semple G; Behan DP; Connolly DT; Lai E; Wagner JA; Wright SD; Cuffie C; Mitchel YB; Rader DJ; Paolini JF; Waters MG; Plump A
    Sci Transl Med; 2012 Aug; 4(148):148ra115. PubMed ID: 22914621
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Niacin-induced hyperglycemia is partially mediated via niacin receptor GPR109a in pancreatic islets.
    Chen L; So WY; Li SY; Cheng Q; Boucher BJ; Leung PS
    Mol Cell Endocrinol; 2015 Mar; 404():56-66. PubMed ID: 25622782
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression and localization of GPR109A (PUMA-G/HM74A) mRNA and protein in mammalian retinal pigment epithelium.
    Martin PM; Ananth S; Cresci G; Roon P; Smith S; Ganapathy V
    Mol Vis; 2009; 15():362-72. PubMed ID: 19223991
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Activation of Gpr109a, receptor for niacin and the commensal metabolite butyrate, suppresses colonic inflammation and carcinogenesis.
    Singh N; Gurav A; Sivaprakasam S; Brady E; Padia R; Shi H; Thangaraju M; Prasad PD; Manicassamy S; Munn DH; Lee JR; Offermanns S; Ganapathy V
    Immunity; 2014 Jan; 40(1):128-39. PubMed ID: 24412617
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.